# Frequently Asked Questions About the BPC-157 TB-500 GHK-Cu Blend

> BPC-157 TB-500 GHK-Cu blend FAQ: mechanism, dosage, safety, synergy, and regulatory status. Answers drawn from the peer-reviewed literature.

## What is the BPC-157 and TB-500 blend?

The BPC-157 TB-500 blend is a research peptide stack combining BPC-157 (a 15-amino-acid gastric-derived repair peptide) and TB-500 (the Ac-LKKTETQ synthetic fragment of thymosin beta-4). Each targets a different repair pathway: BPC-157 via VEGFR2-mediated angiogenesis and fibroblast activation [1][2][3]; TB-500 via G-actin sequestration and cell migration [9][19]. The BPC-157 TB-500 GHK-Cu blend adds GHK-Cu for extracellular matrix remodeling [14][15]. No peer-reviewed study has examined the combination in co-administration.

## How long does it take for BPC-157 and TB-500 to kick in?

In rat tendon and muscle models, measurable tissue changes appear within 7–14 days with BPC-157 [4][8]. Thymosin beta-4 studies show reepithelialization 42% faster than controls by day 4 and 61% by day 7 [10]. No validated human timeline exists. GHK-Cu liposomal wound closure was shortened to 14 days in a mouse scald model [17].

## How much BPC-157 and TB-500 should I take?

Animal studies used BPC-157 at ~10 μg/kg subcutaneously or intraperitoneally [4][8]; TB-500 at 0.5–10 mg/kg in rodent wound models [22]. These figures do not translate directly to human dosing. No clinical trial has established a therapeutic human dose for either compound.

## Can BPC-157 cause liver damage?

No peer-reviewed study has demonstrated hepatotoxicity from BPC-157. Rat studies investigating NSAID-induced liver injury found BPC-157 attenuated liver damage — normalizing elevated bilirubin, AST, and ALT [5]. The hepatoprotective direction is the opposite of liver damage.

## Is BPC-157 bad for the heart?

No rodent study has demonstrated direct cardiotoxicity. BPC-157 induced vasodilation via the Src-Caveolin-1-eNOS pathway — researchers noted potential cardiovascular-protective implications [2]. Three human pilot studies reported no adverse cardiovascular events [21].

## What does GHK-Cu peptide do?

GHK-Cu stimulates collagen and elastin synthesis, upregulates antioxidant enzymes (SOD, catalase), promotes angiogenesis via VEGF and FGF-2 upregulation, and modulates ~4,000 human genes [14][15][16][17]. Plasma GHK naturally declines from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 [14].

## What are the risks of taking GHK-Cu peptide?

No significant toxicity has been reported at research doses across decades of published research [14][15]. Theoretical risk of copper excess at very high systemic exposure. Injectable human pharmacokinetic and safety data for GHK-Cu are not available in the peer-reviewed literature [26].

## How long does it take GHK-Cu to tighten skin?

A 12-week placebo-controlled topical study found improved collagen density in 70% of subjects [14]. GHK-Cu liposomes shortened wound healing to 14 days in a mouse scald model [17]. Injectable or systemic human timelines have not been characterized. Topical penetration limited by GHK-Cu's hydrophilic nature [26].

## What is TB-500 used for?

Soft-tissue repair, angiogenesis promotion, inflammation reduction, and improved tissue flexibility — primarily in equine veterinary and rodent injury models [9][10][11]. The parent molecule thymosin beta-4 has advanced to Phase 3 clinical trials for corneal and dermal repair [9][19]. Hair follicle activation is also a documented research application [11][12][13].

## What are the side effects of TB-500?

No significant adverse signals in rodent or equine wound healing models [9][10]. Some human users report transient nausea, fatigue, or injection-site discomfort — observational reports not captured in a controlled human safety trial. No published peer-reviewed human safety study for the Ac-LKKTETQ fragment.

## Does TB-500 increase hair growth?

Transgenic mouse models show faster hair regrowth with TB4 overexpression and slower cycling in knockouts, via Wnt/beta-catenin/Lef-1 and VEGF/MMP-2 signaling [12][13]. Systemic TB4 promoted hair follicle cycling in normal and aged rodents [11]. No published human clinical trial has specifically studied TB-500 for hair growth.

## Is GHK-Cu really anti-aging?

"Anti-aging" is a marketing label; the mechanisms have peer-reviewed support. GHK-Cu activates over 4,000 human genes including antioxidant defense and collagen synthesis genes [15]. Topical formulations improved skin appearance in placebo-controlled human trials [14]. The 2024 review confirms collagen synthesis enhancement while noting a surprising absence of large-scale clinical trials [26].

## Does copper peptide help fade scars?

GHK-Cu increases matrix metalloproteinase activity and fibronectin production — mechanisms relevant to scar tissue remodeling [14][15]. Human clinical data on scarring is limited to small observational studies.

## Does copper peptide work for hair growth?

AHK-Cu (closely related to GHK-Cu) stimulated elongation of human hair follicles ex vivo and proliferation of dermal papilla cells in vitro [18]. Small human studies with topical GHK-Cu showed increased hair density [14].

## Has anyone tried BPC-157 and TB-500 together?

No randomized controlled trial has studied the combination. Mechanistically, BPC-157 via VEGFR2/NO modulation and TB-500 via actin sequestration address complementary repair stages [1][2][9][20]. No co-administration data exists.

## Why is the FDA banning BPC-157?

The FDA placed BPC-157 on its bulk drug substances list for compounding restrictions in 2023, citing lack of approved clinical trials. It has entered clinical trials as PL 14736 for IBD without an approved indication [21][22]. Research use is a separate legal category.

## Does orally administered BPC-157 enter the bloodstream?

Rat studies show oral BPC-157 produces systemic effects, suggesting partial absorption [22]. BPC-157 is stable in gastric juice >24 hours [7]. No validated human pharmacokinetic data exists.

## Is it safe to take TB-500 peptide?

No significant toxicity in rodent and equine models [9][10]. Human safety for the synthetic Ac-LKKTETQ fragment has not been established in peer-reviewed controlled trials. TB-500 is prohibited at all times under WADA Prohibited List S2.

## How to reconstitute BPC-157 TB-500 blend?

Research protocols describe reconstitution with bacteriostatic water (0.9% benzyl alcohol saline) at 1–2 mg/mL [24]. GHK-Cu solution turns blue-green — expected copper(II) chelation, not degradation [24]. Store lyophilized vials at −20°C long-term.

## What is the BPC-157 TB-500 blend dosage calculator?

Animal studies used BPC-157 at ~10 μg/kg (IP) and TB-500 at 0.5–10 mg/kg; common research vials contain 5 mg:5 mg or 10 mg:10 mg blends [4][22]. These figures do not constitute a validated human dosage calculator.

## How often to inject BPC-157 and TB-500?

Rodent studies: BPC-157 once daily [4][8]; TB-500 daily to twice-weekly depending on model. No consensus human injection frequency exists in the peer-reviewed literature.

---

Three growing literatures, one reading room — each study pressed and labeled here, sold by no one and prescribed by no one.